Oregon Health and Sciences University
Oregon Health and Sciences University
Portland, Oregon, United States20 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis | Coronary Artery Disease Progression; Coronary Artery Disease Risk Factors Multiple; Premature Atherosclerosis; Prevention & Control | Recruiting | Phase 3 | 2026-10-07 | NCT07232069 | |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06872892 | |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) | B-cell neoplasm, B-cell non-Hodgkin lymphoma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, primary central nervous system lymphoma, primary effusion lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT06343311 | |
| A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | acquired idiopathic inflammatory myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease | Not yet recruiting | Phase 3 | 2026-09-30 | NCT07789015 | |
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-10 | NCT04864054 | |
| Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial | Intraoperative Awareness, Intraoperative Complications, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Not applicable | 2026-09-04 | NCT05991453 | |
| Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Recruiting | Phase 2 | 2026-09-02 | NCT07292298 | |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum | Skin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular disease | Recruiting | Phase 3 | 2026-09-02 | NCT06624670 | |
| A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 1 / Phase 2 | 2026-07-08 | NCT06138639 | |
| BLOCK-SAH - PPF-Block for Post-SAH Headache | Headache, Hemorrhage, Intracranial Hemorrhages, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Recruiting | Phase 2 | 2026-07-06 | NCT06008795 | |
| Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 3 | 2026-06-22 | NCT07007962 | |
| Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults | acute respiratory failure | Recruiting | Not stated | 2026-05-11 | NCT06934876 | |
| Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis | graft versus host disease, immune system disorder | Recruiting | Phase 2 | 2026-05-11 | NCT04380740 | |
| Lumason® Infusion vs. Bolus Administrations | cardiovascular disorder, heart disorder | Recruiting | Phase 3 | 2026-03-05 | NCT06400004 | |
| COVID-19 Reactogenicity | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 4 | 2026-03-04 | NCT07051031 | |
| Validation of i-ROP DL to Detect More Than Mild ROP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, eye disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Not applicable | 2025-12-17 | NCT06109285 | |
| SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Active, not recruiting | Phase 2 | 2025-10-31 | NCT04803877 | |
| Pediatric Dose Optimization for Seizures in Emergency Medical Services | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2025-09-30 | NCT05121324 | |
| Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients | Critical Illness, Disease Attributes, Hyperoxia, Hypoxia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, burn, injury | Active, not recruiting | Phase 3 | 2025-04-02 | NCT04534959 | |
| Post-Market Clinical Investigation of the IotaSOFT Insertion System | Ear Diseases, Hearing Loss, Cochlear, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease | Recruiting | Not stated | 2024-10-31 | NCT06664697 |